| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $32.0M | +17.4% |
| Cost of Revenue | $10.4M | +26.3% |
| Gross Profit | $21.7M | +13.6% |
| R&D Expense | $7.2M | -1.4% |
| SG&A Expense | $24.5M | -17.4% |
| Operating Income | -$84.4M | -65.2% |
| Pre-tax Income | -$82.1M | -72.8% |
| Income Tax | -$278K | +50.1% |
| Net Income | -$81.9M | -74.2% |
| EPS (Basic) | -$0.08 | -60.0% |
| EPS (Diluted) | -$0.08 | -60.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.0M | +28.4% |
| Accounts Receivable | $3.0M | +24.3% |
| Inventory | $5.5M | +9.6% |
| Current Assets | $64.0M | -21.7% |
| Total Assets | $127.0M | -38.7% |
| Current Liabilities | $9.4M | +1.3% |
| Total Liabilities | $11.6M | -0.5% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.6M | +25.3% |
| Capital Expenditures | $567K | -89.1% |
| Investing Cash Flow | $19.6M | +9.6% |
| Financing Cash Flow | -$70K | +0.0% |
| Free Cash Flow | -$18.2M | +36.8% |
| $115.4M |
| -41.0% |